← back to search

Maria C. Russell

Emory Healthcare · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Gastric Cancer Management and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis, and Neuroendocrine Tumor Research Advances.
h-index
30
citations
3,271
works
262
NIH funding
primary concept
email

Recent publications

Implementation of a Hepatocellular Carcinoma Screening Program for At-risk Patients Safety-Net Hospital: A Model for National Dissemination
Annals of Surgery 2022cited by 12position: lastdoi
Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals
Journal of Surgical Oncology 2021cited by 10position: middledoi
Optimal timing and treatment strategy for pancreatic cancer
Journal of Surgical Oncology 2020cited by 40position: middledoi
Impact of hepatitis C treatment on long-term outcomes for patients with hepatocellular carcinoma: a United States Safety Net Collaborative Study
HPB 2020cited by 17position: lastdoi
Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study
Annals of Surgical Oncology 2020cited by 16position: middledoi
Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative
Surgical Oncology 2020cited by 13position: lastdoi
Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis
Journal of Surgical Oncology 2020cited by 12position: middledoi
Historical perspective: Two decades of progress in treating metastatic colorectal cancer
Journal of Surgical Oncology 2019cited by 62position: lastdoi
Race, ethnicity, and socioeconomic factors in cholangiocarcinoma: What is driving disparities in receipt of treatment?
Journal of Surgical Oncology 2019cited by 29position: middledoi
Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative
Annals of Surgical Oncology 2019cited by 27position: middledoi
What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative
Clinical Colorectal Cancer 2019cited by 23position: lastdoi
Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
Journal of Surgical Oncology 2019cited by 22position: middledoi
Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium
The American Surgeon 2017cited by 79position: middledoi
A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial
Annals of Surgical Oncology 2017cited by 25position: middledoi
Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II
Annals of Surgical Oncology 2017cited by 23position: middledoi
Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases
Modern Pathology 2016cited by 73position: middledoi
Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy
Journal of Surgical Oncology 2016cited by 55position: middledoi
Small bowel neuroendocrine tumors: A critical analysis of diagnostic work‐up and operative approach
Journal of Surgical Oncology 2016cited by 39position: middledoi
A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?
Journal of Surgical Oncology 2016cited by 23position: middledoi
Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
Journal of the American Academy of Dermatology 2015cited by 168position: middledoi
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach
Annals of Surgical Oncology 2015cited by 103position: middledoi
Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative
Journal of the American College of Surgeons 2015cited by 86position: middledoi
Value of Primary Operative Drain Placement after Major Hepatectomy: A Multi-Institutional Analysis of 1,041 Patients
Journal of the American College of Surgeons 2015cited by 38position: middledoi
An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven‐institution analysis of 837 patients from the U.S. gastric cancer collaborative
Journal of Surgical Oncology 2015cited by 35position: middledoi
Is It Time to Abandon the 5-cm Margin Rule During Resection of Distal Gastric Adenocarcinoma? A Multi-Institution Study of the U.S. Gastric Cancer Collaborative
Annals of Surgical Oncology 2014cited by 65position: middledoi
Cost comparison analysis of open versus laparoscopic distal pancreatectomy
HPB 2014cited by 43position: middledoi
Association Between Hospital Finances, Payer Mix, and Complications After Hyperthermic Intraperitoneal Chemotherapy: Deficiencies in the Current Healthcare Reimbursement System and Future Implications
Annals of Surgical Oncology 2014cited by 31position: middledoi
The Effect of Preoperative Renal Insufficiency on Postoperative Outcomes after Major Hepatectomy: A Multi-Institutional Analysis of 1,170 Patients
Journal of the American College of Surgeons 2014cited by 26position: middledoi
The effect of perioperative transfusion on recurrence and survival following gastric cancer resection: A seven-institution analysis of 765 patients from the U.S. Gastric Cancer Collaborative.
Journal of Clinical Oncology 2014cited by 0position: middledoi
A Novel Risk-Adjusted Nomogram for Rectal Cancer Surgery Outcomes
JAMA Surgery 2013cited by 56position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Shishir K. Maithel · Robert H. Lurie Comprehensive Cancer Center of Northwestern University21 papers (2013–2022)Charles A. Staley · Emory University18 papers (2013–2022)David A. Kooby · Emory University17 papers (2013–2020)Kenneth Cardona · Dana-Farber Cancer Institute15 papers (2012–2020)Malcolm H. Squires · Levine Cancer Institute12 papers (2013–2017)Rachel Lee · Grand Rapids Community College10 papers (2019–2022)Sharon M. Weber · Northwell Health7 papers (2014–2017)Lauren M. Postlewait · Grady Memorial Hospital6 papers (2015–2017)Clifford Suhyun Cho · Michigan Medicine6 papers (2014–2015)Emily R. Winslow · University of Wisconsin–Madison6 papers (2014–2015) · 5 papers (2020–2021)Eric J. Silberfein · Baylor College of Medicine5 papers (2020–2021)Timothy M. Pawlik · University of Tampa5 papers (2014–2017)George A. Poultsides · Stanford University5 papers (2014–2017)Cary Hsu · Baylor College of Medicine5 papers (2020–2021)Adriana C. Gamboa · The University of Texas MD Anderson Cancer Center5 papers (2019–2020)Ryan C. Fields · University of Missouri–St. Louis5 papers (2014–2017)Adam C. Yopp · Parkland Health & Hospital System5 papers (2020–2021)Emily L. Ryon · University of Miami5 papers (2020–2021)Carl Schmidt · West Virginia University5 papers (2014–2017)